S. Sivgin Et Al. , "The evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34+peripheral hematopoietic stem cell mobilisation procedures for alloHSCT donors," 41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , vol.50, İstanbul, Turkey, 2015
Sivgin, S. Et Al. 2015. The evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34+peripheral hematopoietic stem cell mobilisation procedures for alloHSCT donors. 41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , (İstanbul, Turkey).
Sivgin, S., KARAKUŞ, E., Keklik, M., ZARARSIZ, G., SOLMAZ, M., KAYNAR, L., ... ESER, B.(2015). The evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34+peripheral hematopoietic stem cell mobilisation procedures for alloHSCT donors . 41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey
Sivgin, Serdar Et Al. "The evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34+peripheral hematopoietic stem cell mobilisation procedures for alloHSCT donors," 41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, İstanbul, Turkey, 2015
Sivgin, Serdar Et Al. "The evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34+peripheral hematopoietic stem cell mobilisation procedures for alloHSCT donors." 41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , İstanbul, Turkey, 2015
Sivgin, S. Et Al. (2015) . "The evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34+peripheral hematopoietic stem cell mobilisation procedures for alloHSCT donors." 41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , İstanbul, Turkey.
@conferencepaper{conferencepaper, author={Serdar ŞIVGIN Et Al. }, title={The evaluation of the efficacy and safety of original filgrastim (Neupogen (R)), biosimilar filgrastim (Leucostim (R)) and Lenograstim (Granocyte (R)) in CD34+peripheral hematopoietic stem cell mobilisation procedures for alloHSCT donors}, congress name={41st Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation}, city={İstanbul}, country={Turkey}, year={2015}}